It has been shown that BRCA1 mRNA expression levels are the lowest in tumours of mutation carriers, intermediate in tumours of sporadic cancers, and highest in the surrounding normal tissues from either mutation carriers or sporadic cancers (Kainu et al, 1996). Here, BRCA1 is linked to neoplasm.